L-tetrahydropalmatine attenuates cisplatin-induced nephrotoxicity via selective inhibition of organic cation transporter 2 without impairing its antitumor efficacy
- 1 July 2020
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 177, 114021
- https://doi.org/10.1016/j.bcp.2020.114021
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (81503147, 81872929)
- Foundation of Zhejiang Traditional Chinese Medicine (2016ZZ014)
This publication has 46 references indexed in Scilit:
- Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in miceKidney International, 2014
- l-Tetrahydropalmatine, an Active Component of Corydalis yanhusuo W.T. Wang, Protects against Myocardial Ischaemia-Reperfusion Injury in RatsPLOS ONE, 2012
- Stereoselective metabolism of tetrahydropalmatine enantiomers in rat liver microsomesChirality, 2012
- Induction of Oxidative Stress in KidneyInternational Journal of Nephrology, 2012
- An integrative view of the pathophysiological events leading to cisplatin nephrotoxicityCritical Reviews in Toxicology, 2011
- Comparative Nephrotoxicity of Cisplatin and Nedaplatin:Mechanisms and Histopathological CharacteristicsJournal of Toxicologic Pathology, 2011
- Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective InterventionsThe American Journal of Pathology, 2010
- Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: Experiments with self-administration and brain-stimulation reward in ratsNeuropharmacology, 2007
- Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews, 2007
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005